Low penetrance hereditary retinoblastoma in a family: what should we consider in the genetic counselling process and follow up?

Catarina Serrano1, Javier Alonso2, Gema Gómez-Mariano2, Elena Aguirre3, Orland Díez4, Neus Gadea1, N. Bosch1, Judith Balmañà1, Begoña Graña1
1High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
2Unidad de Tumores Sólidos Infantiles (BSD-TSI), Área de Biología Celular y del Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
3Family Cancer Unit, Medical Oncology Department, Arnau de Vilanova Hospital, Lleida, Spain
4Oncogenetics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Seregard S, Lundell G, Svedberg H et al (2004) Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis. Ophthalmology 111:1228–1232

Corson TW, Gallie BL (2007) One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 46(7):617–634

Burkhart DL, Sage J (2008) Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8:671–682

Harbour JW (2001) Molecular basis of low-penetrance retinoblastoma. Arch Ophthalmol 119:1699–1704

Fletcher O, Easton D, Anderson K et al (2004) Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 96:357–363

Marees T, Moll AC, Imhof SM et al (2008) Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst 100:1771–1779

Alonso J, García-Miguel P, Abelairas J et al (2001) Spectrum of germline RB1 gene mutations in spanish retinoblastoma patients: Phenotypic and molecular epidemiological implications. Hum Mutat 17:412–422

Alonso J, Garcia-Miguel P, Abelairas J et al (2001) A microsatellite fluorescent method for linkage analysis in familial retinoblastoma and deletion detection at the RB1 locus in retinoblastoma and osteosarcoma. Diag Mol Pathol. 10:9–14

Strong LC, Knudson AG Jr (1973) Letter. Second cancers in retinoblastoma. Lancet 2:1086

Yu CL, Tucker MA, Abramson DH et al (2009) Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst 101:581–591

Kleinerman RA, Tucker MA, Tarone RE et al (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23:2272–2279

Tanguay C, Harvey I, Houde M et al (2003) Leiomyosarcoma of urinary bladder following cyclophosphamide therapy: report of two cases. Mod Pathol 16:512–514

Moss SD, Rockswold GL, Chou SN et al (1988) Radiation-induced meningiomas in pediatric patients. Neurosurgery 22:758–761

Kivelä T, Asko-Seljavaara S, Pihkala U et al (2001) Sebaceous Carcinoma of the Eyelid Associated with Retinoblastoma. Ophthalmology 108:1124–1128

Valverde JR, Alonso J, Palacios I et al (2005) RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. BMC Genet 6:53

Shields CL, Honavar SG, Meadows AT et al (2002) Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 120:1653–1658

Kleinerman RA, Tarone RE, Abramson DH et al (2000) Hereditary retinoblastoma and risk of lung cancer. J Natl Cancer Inst 92:2037–2039

Foster MC, Kleinerman RA, Abramson DH et al (2006) Tobacco use in adult long-term survivors of retinoblastoma. Cancer Epidemiol Biomark Prev 15:1464–1468

Dommering CJ, van den Heuvel MR, Moll AC et al (2010) Reproductive decision-making: a qualitative study among couples at increased risk of having a child with retinoblastoma. Clin Genet 78:334–341